🇺🇸 FDA
Patent

US 9724345

Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

granted A61KA61K31/255A61K31/496

Quick answer

US patent 9724345 (Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same) held by Platform Brightworks Two, Ltd. expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Platform Brightworks Two, Ltd.
Grant date
Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/255, A61K31/496, A61K47/02, A61K47/10